PRVA

Privia Health Group, Inc. (PRVA) - Q2 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Privia Health Group, Inc. is a technology-driven, national physician-enablement company operating in 16 markets across the United States. The company organizes physicians into Medical Groups to achieve better outcomes, lower costs, and improved patient experiences through a mix of Fee-for-Service (FFS) and Value-Based Care (VBC) models.

Key Financial Metrics

Non-GAAP Highlights (YTD 2025): Adjusted EBITDA was $55.9 million (25.4% margin). Practice Collections totaled $1.66 billion. Implemented Providers reached 5,125, and Attributed Lives reached 1.38 million.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 23.4% quarter-over-quarter and 19.5% year-over-year (YTD). Growth was driven by FFS-patient care (+20.2% QoQ), shared savings (+50.7% QoQ), and capitated revenue (+33.8% QoQ).
• Operating Expenses: Total operating expenses rose 24.1% QoQ. Provider expenses increased 25.9% due to higher revenue and provider growth. General and administrative expenses rose 29.8%, driven by increased salaries, professional services, and stock-based compensation.
• Profitability: While revenue grew significantly, Operating Income decreased 34.6% QoQ to $3.3 million, primarily due to the timing of shared savings accruals and increased operating costs outpacing revenue growth in the quarter. However, YTD Operating Income increased 44.5%.
• Cash Flow: Operating cash flow turned negative ($16.1 million used) YTD 2025 compared to positive ($1.3 million) in 2024. This was driven by a $121.5 million increase in accounts receivable and a $21.3 million increase in prepaid assets, offset partially by an $81.2 million increase in provider liability.
• Acquisitions: The company acquired a 51% interest in Privia Medical Group Arizona (PMG AZ) in April 2025 for a net cash payment of $89.1 million. This contributed $17.7 million in revenue from acquisition date to period end.

Guidance, Outlook, and Risks

Management Commentary: Management attributes growth to organic expansion and new market entries (Indiana and Arizona). The company continues to invest in sales, marketing, and technology, which has slowed the growth rate of margins relative to revenue. The company expects to continue moving markets toward Value-Based Care (VBC) and increasing risk levels in payer contracts.

Risks and Contingencies:

• Regulatory Environment: Significant exposure to changes in healthcare laws, reimbursement rates, and government regulations.
• Concentration Risk: Three major payers accounted for 60% of revenue in Q2 2025 (Payer A: 29%, Payer B: 16%, Payer C: 15%).
• Acquisition Integration: Risks associated with integrating new markets and meeting earn-out targets (up to $25 million contingent on future performance for the Arizona acquisition).
• Technology Dependence: Reliance on third-party vendors, specifically athenahealth for EMR services.

Guidance: The filing does not provide specific numerical guidance for the full year 2025, stating that results for the first half are not indicative of full-year expectations.

Investor Verification Checklist

• Accounts Receivable Growth: Verify the sustainability of the $127.8 million increase in accounts receivable (from $316M to $444M) and its impact on future cash collections.
• Operating Margin Compression: Analyze the drivers behind the 34.6% drop in Q2 operating income despite 23.4% revenue growth.
• Acquisition Accretion: Monitor the integration of the Arizona acquisition and the realization of the $25 million earn-out potential.
• Provider Liability Estimates: Review the actuarial assumptions used for the $458 million provider liability balance, particularly regarding at-risk capitation claims.
• Stock-Based Compensation: Assess the impact of the $36.6 million YTD stock-based compensation expense on future profitability as awards vest.